SEC Form 4 · accession 0001235802-19-000010
Wright Medical Group N.V. · WMGI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin C Oboyle
Director
Period of report
Jan 30, 2019
Accepted (ET)
Feb 1, 2019 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492658
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value EUR 0.03 per shareF2 | Jan 30, 2019 | M | 1,907 | $22.50 | A | 24,297 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF3,F2 | Jan 30, 2019 | S | 1,907 | $30.00 | D | 22,390 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF2 | Jan 31, 2019 | M | 30,816 | $22.50 | A | 53,206 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF4,F2 | Jan 31, 2019 | S | 30,816 | $30.0677 | D | 22,390 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F5 | $22.50 | Jan 30, 2019 | M | 1,907 | D | — | Jun 3, 2020 | Ordinary Shares | 1,907 | 30,816 | D |
| Stock Option (right to buy)F5 | $22.50 | Jan 31, 2019 | M | 30,816 | D | — | Jun 3, 2020 | Ordinary Shares | 30,816 | 0 | D |
Explanation of responses
- F1These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.
- F2Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.10, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.19, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
- F5This option has fully vested.